News in the antifungal world: new drugs and resistance mechanisms

09 July 2021
6. Fungal infection & disease, 1-hour Oral Session
S103 13:15 > 14:15 News in the antifungal world: new drugs and resistance mechanisms 6. Fungal infections

13:15 2993 EUCAST ibrexafungerp (SCY-078) MICs for contemporary Danish yeast isolates > M. Maiken Cavling ARENDRUP (Copenhagen) 13:25 1046 Activity of manogepix, the active moiety of fosmanogepix against infrequently encountered yeast and mould isolates from the SENTRY antimicrobial surveillance programme (2017-2019) > M. Michael D. HUBAND (North Liberty) 13:35 2708 In-host acquisition of high-level amphotericin B resistance and identification of the first mechanism of clinical amphotericin B resistance in <em>Candida auris</em> > J. Jeffrey RYBAK (Memphis) 13:45 1362 <em>Candida parapsilosis</em> clinical azole cross-resistance acquisition is prompted by <em>MRR1</em> gain-of-function mutation > J. Joana BRANCO (Porto) 13:55 3138 Analysis of multiple resistance genes in <em>Candida glabrata</em> using targeted resequencing with multiplex long-range PCR > K. Kathrin SPETTEL (Vienna) 14:05 INT9 Q&A/Discussion

Copyright © key4events - All rights reserved